Your browser doesn't support javascript.
loading
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
Palleschi, Michela; Maltoni, Roberta; Sarti, Samanta; Melegari, Elisabetta; Bravaccini, Sara; Rocca, Andrea.
Affiliation
  • Palleschi M; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Maltoni R; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Sarti S; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Melegari E; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Bravaccini S; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Rocca A; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Breast J ; 26(4): 739-742, 2020 04.
Article in En | MEDLINE | ID: mdl-31612573
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Italy